Indications |
Oral Prophylaxis of postpartum haemorrhage Adult: 200 mcg 3-4 times daily in the puerperium for 2-7 days. Intramuscular Treatment and prophylaxis of postpartum and postabortal haemorrhage Adult: 200 mcg. May repeat every 2-4 hr. Max: 5 doses. Intravenous Treatment and prophylaxis of postpartum and postabortal haemorrhage Adult: As an emergency measure: 200 mcg by slow inj over at least 1 minute, may repeat every 2-4 hr, up to a max of 5 doses. |
Contraindications |
Hypertension, eclamptic or previously hypertensive patients, heart disease, venoatrial shunts, mitral valve stenosis, obliterative vascular disease. Do not use in cases of threatened spontaneous abortion. Pregnancy. |
Warnings / Precautions |
Captivation of the placenta may occur if given during the 2nd or 3rd stage of labour prior to delivery of the placenta; use in this situation should only be done by a qualified personnel. Avoid prolonged use. Caution in patients with sepsis, hepatic or renal impairment. Lactation. |
Adverse Reactions |
Headache, dizziness, hallucinations; tinnitus; nausea, vomiting, foul taste, diarrhoea; hypertension, temporary chest pain, palpitations, bradycardia; nasal congestion, dyspnoea; diaphoresis; thrombophlebitis; haematuria; water intoxication; leg cramps; allergic reactions. Potentially Fatal: Shock. |
Overdose Reactions |
Symptoms: Prolonged gangrene, numbness in extremities, acute nausea, vomiting, abdominal pain, respiratory depression, changes in BP, seizures. Management: Symptomatic and supportive. |
Drug Interactions |
Possible increase in serum levels and risk of severe vasoconstrictive effects with potent CYP3A4 inhibitors (e.g. erythromycin, troleandomycin, clarithromycin, ritonavir, indinavir, nelfinavir, delavirdine, ketoconazole, itraconazole, voriconazole) and less potent CYP3A4 inhibitors (e.g. saquinavir, nefazodone, fluconazole, fluoxetine, fluvoxamine, zileuton, clotrimazole). See Below for More methylergometrine Drug Interactions |
Food Interactions |
Possible increase in serum levels and risk of severe vasoconstrictive effects with grapefruit juice. |
Mechanism of Actions |
Methylergometrine is an ergot alkaloid, which directly stimulates contractions of uterine and vascular smooth muscle. Onset: 5-15 min (oral); 2-5 min (IM); immediate (IV). Duration: ≥3 hr (oral/IM); 45 min (IV). Absorption: Rapidly absorbed (oral; IM). Distribution: Mainly distributed into plasma and extracellular fluid; rapidly distributed into tissues. Enters the breast milk. Metabolism: Hepatic: Undergoes first-pass metabolism. Excretion: Mainly via faeces; via urine (small amounts as unchanged drug); 2-3 hr (elimination half-life). |
Storage Conditions |
Intramuscular: Store under refrigeration at 2-8°C (36-46°F). Protect from light. Intravenous: Store under refrigeration at 2-8°C (36-46°F). Protect from light. Oral: Store below 25°C (77°F). |
ATC Classification |
G02AB01 - methylergometrine ; Belongs to the class of ergot alkaloids. Used to induce abortion or augment labour and to minimize blood loss from the placental site. |
Storage |
Intramuscular: Store under refrigeration at 2-8°C (36-46°F). Protect from light. Intravenous: Store under refrigeration at 2-8°C (36-46°F). Protect from light. Oral: Store below 25°C (77°F). |
Available As |
|
Ergometrine
Post Review about Ergometrine Click here to cancel reply.
Ergometrine Containing Brands
Ergometrine is used in following diseases
Drug - Drug Interactions of Ergometrine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.